Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.
about
Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phase I study of alternating d ...... osed, advanced ovarian cancer.
@ast
Phase I study of alternating d ...... osed, advanced ovarian cancer.
@en
type
label
Phase I study of alternating d ...... osed, advanced ovarian cancer.
@ast
Phase I study of alternating d ...... osed, advanced ovarian cancer.
@en
prefLabel
Phase I study of alternating d ...... osed, advanced ovarian cancer.
@ast
Phase I study of alternating d ...... osed, advanced ovarian cancer.
@en
P2093
P356
P1433
P1476
Phase I study of alternating d ...... osed, advanced ovarian cancer.
@en
P2093
Alan N Gordon
C A Stringer
Carolyn M Matthews
Kenneth C Hancock
Mark G Doherty
Mark Messing
Michael Teneriello
P304
P356
10.1006/GYNO.2001.6581
P407
P577
2002-04-01T00:00:00Z